tradingkey.logo
tradingkey.logo
검색

Biofrontera Inc

BFRI
관심 목록에 추가
1.010USD
0.0000.00%
종가 07/02, 13:00ET시세는 15분 지연됩니다
11.76M시가총액
손실P/E TTM

자세한 내용은 Biofrontera Inc 회사

Biofrontera Inc. is a biopharmaceutical company. The Company specializes in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT). The PDT treatment is used for the lesion-directed and field-directed treatment of actinic keratoses of mild-to-moderate severity on the face and scalp. The Company’s primary licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (the RhodoLED Lamps), are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions. The Company commercializes the drug-device combination Ameluz with the RhodoLED lamp series for PDT of AK, pre-cancerous skin lesions which may progress to invasive skin cancers. Its belixos ACTIVE CARE is a skin-soothing care foam for irritated and itchy skin, which can be used as basic care for atopic dermatitis and psoriasis as well as for soothing intensive care for everyday skin problems.

Biofrontera Inc 정보

종목 코드 BFRI
회사 이름Biofrontera Inc
상장일Oct 14, 2021
CEOLuebbert (Hermann)
직원 수92
유형Ordinary Share
회계 연도 종료Oct 14
주소120 Presidential Way,
도시WOBURN
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가United States of America
우편 번호01801
전화17812451325
웹사이트https://www.biofrontera-us.com/
종목 코드 BFRI
상장일Oct 14, 2021
CEOLuebbert (Hermann)

Biofrontera Inc의 회사 임원진

이름
이름/직위
직위
주식 보유
변동
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--
Mr. George Jones
Mr. George Jones
Chief Commercial Officer
Chief Commercial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Prof. Dr. Hermann Luebbert, Ph.D.
Prof. Dr. Hermann Luebbert, Ph.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
290.21K
+47.38%
Mr. Eugene Frederick (Fred) Leffler, III
Mr. Eugene Frederick (Fred) Leffler, III
Chief Financial Officer
Chief Financial Officer
175.00K
+50.00%
Dr. John J. Borer, III
Dr. John J. Borer, III
Independent Director
Independent Director
--
--
Dr. Beth J. Hoffman, Ph.D.
Dr. Beth J. Hoffman, Ph.D.
Independent Director
Independent Director
--
--
Mr. Kevin D. Weber
Mr. Kevin D. Weber
Independent Director
Independent Director
--
--
Dr. Heikki Lanckriet, Ph.D.
Dr. Heikki Lanckriet, Ph.D.
Director
Director
--
--

자주 묻는 질문

Biofrontera Inc의 상위 5대 주주는 누구인가요?

Biofrontera Inc의 상위 5대 주주는 다음과 같습니다: Prof. Dr. Hermann Luebbert, Ph.D.

Biofrontera Inc(BFRI)의 주식을 보유한 기관은 몇 개입니까?

2026Q1 기준으로, Biofrontera Inc의 주식을 보유한 기관은 총 37곳이며, 이들이 보유한 주식의 총 가치는 약 2.75M로 전체 발행 주식의 22.90%를 차지합니다. 이는 2025Q4 대비 -276665.00 증가한 수치입니다.